The project aims to promote innovation in SMEs in the EU in the ICT, Healthcare, BIO and Medicine sectors. The objective of INNOLABS is to offer new products and services for healthcare development based on the capacity of European SMEs belonging to the ICT, Health, BIO and Medicine sectors.

INNOLABS aims to foster collaboration, knowledge transfer and opportunities among SMEs from different countries and sectors in order to develop, improve and offer disruptive technologies primarily related to mHealth, personalised healthcare services and ageing populations.

The INNOLABS consortium is made up of eight partners from seven different countries. The project launched on 1 January 2017 and will last for 2.5 years. This project has received funding from the European Horizon 2020 Programme for Research and Innovation by virtue of subsidy agreement no. 691556.



The European Commission has granted the CROSS4HEALTH project a subsidy of 5 million Euros, which relies on the support of Horizon 2020, the EU Framework Programme for Research and Innovation. Of the €5M, more than 75% will directly go to supporting innovation in SMEs (more than 3.75 million Euros).

The objective of CROSS4HEALTH is to promote the development of the Emerging Medical Devices Industry by applying innovation, processes and business cultures pertaining to the Aerospace and Energy sectors to the BioTech, ICT and Medicine sectors.

CROSS4HEALTH aims to foster collaboration, knowledge transfer and opportunities among SMEs from different countries and sectors in order to develop, improve and offer disruptive technologies primarily related to ageing populations, chronic diseases and efficient healthcare services.

This project has received funding from the European Union Horizon 2020 Programme for Research and Innovation by virtue of subsidy agreement no. 731391.

Biotecyl participates in CROSS4HEALTH as a partner.



This project, co-funded by the Ministry of Industry, Energy and Tourism, aims to draft a feasibility study to develop a collaborative platform, which serves to approach rare diseases from a multidisciplinary perspective. This approach allows for early diagnosis, ensures high-quality healthcare attention, improves communication and contributes knowledge in the sphere of research in Castilla y León.

In turn, this platform will mean improved competitive standing for the companies in the cluster which develop diagnostic tools and/or possible therapies to treat these diseases.


El OBJETIVO PRINCIPAL del proyecto  es realizar un mapeo de las tecnologías, productos y servicios de los socios de las asociaciones Cluster de Salud de Castilla y León (BIOTECYL), Cluster Soluciones Innovadoras para la Vida Independiente (SIVI) y Cluster de Oftalmología y Ciencias de la Visión (CLUSTER4EYE), con el objetivo final de mejorar la competitividad de nuestros asociados y poner en valor el sector de la SALUD en CyL (sector que representan los 3 Clusters involucrado en el proyecto), y así atraer inversión y talento a nuestra región.

Los RESULTADOS ESPERABLES del proyecto son la obtención de un plan de acción conjunto de impulso del sector de la SALUD planteado con el enfoque colaborativo en el seno de la cooperación regional, que permitirá establecer un catálogo de servicios y tecnologías y actuaciones de transferencia intraclústers dirigidas a la mejora de la competitividad, permitiendo su visibilidad y desarrollo a futuro a nivel nacional e internacional, en entornos europeos de innovación.

Ese proyecto cuenta con el apoyo financiero de la Dirección General de Industria (Consejería de Economía, Junta de Castilla y León) así como del Fondo Europeo de Desarrollo Regional (FEDER).



Co-funded by the Ministry of Industry, Energy and Tourism, Meet-in-Health provides a methodology and tools to aggregate innovative public demand in the healthcare sector for diagnosis, prognosis and choice of treatment.

The primary purpose of this project was to create a methodology and tools to aggregate innovative public demand in the healthcare sector, the implementation of which will provide greater opportunities for our companies to participate in public procurement tenders for innovative technology. Public supply and demand was analysed, identifying the technologies on the market and in the pipeline in Biotecyl’s companies which can respond to the needs that have been identified.

Based on the map of supply/demand, the project concluded with a forum for dialogue and collaboration between Biotecyl, the Public Administration and a pool of clinical professionals from the leading hospitals in the region to explore opportunities in Innovative Public Procurement. With 40 participants, and a large presence from the Public Administration, the Forum was chaired by the Minister of Health, Dr Antonio María Sáez Aguado, who expressed his support for the initiative as well as his confidence in Innovative Public Procurement as an instrument to promote demand-based innovation in healthcare.


The primary objective of this project is to bring industry closer to the healthcare sector to promote and reinforce the transfer of knowledge and the research results from the care centres to the business market.

This project aims to obtain a shared action plan to foster healthcare innovation with a collaborative focus as part of transnational cooperation. This will help establish a network that encourages exchanging good practices, testing and implementing the innovation management model, allowing the model to be transferred to other centres and fostering the companies’ participation in European fields of innovation.



This project, co-funded by the General Directorate of Industry, involved the design and implementation of an innovation office within the field of biomedicine.

The primary objective of the project was to develop a tool that could help the companies and research centres belonging to both Innovative Entrepreneurial Groups become aware of announcements for R+D+I funding opportunities in the field of biomedicine, as well as make it easier for members to search and possibly form consortia by using the websites of both clusters.

In this way, a single point of contact was created to assess project development, aiming to promote development and participation in different calls for tenders as well as to increase the companies’ competitive standing in the field of biomedicine. The aim was to foster collaboration between different types of entities to undertake projects, highlighting the cooperative spirit of this project. The primary challenge was to promote collaboration between companies, both within the same cluster as well as within the intercluster, along with other entities such as Universities and Research Centres..


The primary purpose of this project, co-funded by the Ministry of Industry, Energy and Tourism, was to draft a feasibility study regarding the launch of the High Biosecurity Animal Housing Facility to improve the competitive standing of the companies in the healthcare Sector in Castilla y León.

This Animal Housing Facility is intended to keep large domestic and farm animals (mainly, sheep, cattle and swine), which may be subjected to experimental conditions that involve the use of pathogens included in Group 2 and Group 3 of the Risk Classification of Biological Agents.

Establishing the Animal Housing Facility will improve the competitive standing of the companies in Biotecyl as well as the companies in the sector that need to conduct studies both in animal and human health..


The primary purpose of this study was to provide the elements necessary to prepare the Cluster’s new R+D+I activities and those of its companies and institutions. This initiative allows collaborative projects to be developed both as part of the Cluster as well as with potential clients and highly specialised technology providers, to enhance the added value of the products and services of Biotecyl’s members.

Developing this project has had a strong impact on the two types of actors that form part of our Association (companies and institutions which provide knowledge and/or technology) and therefore in the horizontal activities that we carry out in order to achieve our strategic challenges. Creating the map of existing knowledge and technology in the Cluster has allowed for collaborative R+D+I projects to be implemented with our members participating in national and European programmes. This project has been co-funded by the Ministry of Industry, Energy and Tourism..


The Regional Ministry of the Economy and the Treasury of the Government of Castilla y León has awarded grants that add up to nearly 450,000 Euros to ten clusters that are registered in the Registry of Innovative Business Groups of Castilla y León, including Biotecyl. This funding aims to accelerate their full potential, both by means of enhancing professional training, as well as by reinforcing skills to attract human capital that provides added value, in line with the Autonomous Community’s Plan to Retain, Attract and Bring Back Talent.

  • Excellence: improvement and excellence initiatives in management will be supported by implementing quality labelling and benchmarking promoted by the European Secretariat for Cluster Analysis.
  • Retaining, developing and bringing back talent: measures will be funded to identify specialised employment opportunities in the respective sectors, incentivise recruiting professionals who contribute to the productive fabric in Castilla and León and further understand the factors that prevent the flight of qualified personnel from the Community.

With these initiatives, the programme aims for Innovative Company Groups to be capable of more effectively responding to the present and future needs of the businesses in the autonomous community and contributing to fielding the best human resources for them.

Noticias relacionadas

Biotecyl ha recibido financiación de: